Edwards Lifesciences' Chairman and CEO to Exercise Stock Options Under 10b5-1 Stock Trading Plan

Edwards Lifesciences Corporation EW today announced that in May 2011 its chairman and chief executive officer, Michael A. Mussallem, will begin exercising stock options that are near expiration under a pre-arranged stock trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934. The plan, which Mussallem adopted in November 2010, will provide a vehicle for him to exercise Edwards stock options due to expire in May 2012, and provides for the exercise and sale of up to 70,000 shares per month.